This study is not yet accepting patients

Integrating Nonpharmacologic Strategies for Pain With Inclusion, Respect, and Equity

a study on Pain

Summary

Eligibility
for people ages 18 years and up (full criteria)
Location
at San Francisco, California and other locations
Dates
study started
completion around
Principal Investigator
by Jason Satterfield, PhD

Description

Summary

INSPIRE creates a trilingual mobile app and telehealth coaching program to promote non-pharmacologic strategies for pain management with Black, Chinese, and Latinx communities in the San Francisco Bay Area. Years 1-2 will develop the app and test it with a brief single arm pilot starting in Nov 2023. A full two arm randomized controlled trial (RCT) will being in early 2025 with changes in PEG scores as the primary outcome. Secondary outcomes include Helping to End Addiction Longterm (HEAL) common data elements.

Official Title

Integrating Nonpharmacologic Strategies for Pain With Inclusion, Respect, and Equity (INSPIRE): Tailored Digital Tools, Telehealth Coaching, and Primary Care Coordination

Keywords

Chronic Pain, Non-malignant chronic pain, Digital health, Health coaching, Health equity, Cognitive therapy, Mindfulness, Movement, CBT, Mindfulness, and Movement

Eligibility

You can join if…

Open to people ages 18 years and up

  1. age 18 or older
  2. speak English, Spanish, or Cantonese
  3. have a UCSF Health or SFHN PCP
  4. be willing to use a smartphone (iOS or Android - either their own or one provided by the study)
  5. have chronic, non-malignant pain for at least 3 months
  6. be willing to participate in a 12 month patient-centered chronic pain management study where they will be randomized into one of two comparison arms

You CAN'T join if...

Locations

  • San Francisco General Hospital
    San Francisco California 94110 United States
  • UCSF Adult Primary Care Mt. Zion Clinic
    San Francisco California 94115 United States

Lead Scientist at UCSF

Details

Status
not yet accepting patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, San Francisco
ID
NCT06183281
Study Type
Interventional
Participants
Expecting 586 study participants
Last Updated